Tislelizumab in Combination With Chemotherapy for Conversion Therapy of Locally Nonresectable ESCC
The First Affiliated Hospital with Nanjing Medical University
The First Affiliated Hospital with Nanjing Medical University
Shanghai Zhongshan Hospital
Sun Yat-sen University
Samsung Medical Center
National Taiwan University Hospital
Russian Academy of Medical Sciences
The First Affiliated Hospital of Anhui Medical University
Sun Yat-sen University
Technical University of Munich
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fudan University